BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15213286)

  • 1. Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy.
    Poggio ED; Clemente M; Riley J; Roddy M; Greenspan NS; Dejelo C; Najafian N; Sayegh MH; Hricik DE; Heeger PS
    J Am Soc Nephrol; 2004 Jul; 15(7):1952-60. PubMed ID: 15213286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients.
    Najafian N; Salama AD; Fedoseyeva EV; Benichou G; Sayegh MH
    J Am Soc Nephrol; 2002 Jan; 13(1):252-259. PubMed ID: 11752045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
    Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O
    Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactive T Cells to Identify Risk HLA Alleles for Retransplantation After Acute Accelerated Steroid-Resistant Rejection.
    Leyking S; Wolf M; Mihm J; Schaefer M; Bohle RM; Fliser D; Sester M; Sester U
    Transplant Proc; 2015 Oct; 47(8):2425-32. PubMed ID: 26518945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of immune markers in human cardiac allograft recipients and association with coronary artery vasculopathy.
    Poggio ED; Roddy M; Riley J; Clemente M; Hricik DE; Starling R; Young JB; Gus B; Yamani MH; Heeger PS
    J Heart Lung Transplant; 2005 Oct; 24(10):1606-13. PubMed ID: 16210137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of cellular immunity by interferon-gamma enzyme-linked immunosorbent spot assay in kidney allograft recipients: preliminary results of a longitudinal study.
    Bellisola G; Tridente G; Nacchia F; Fior F; Boschiero L
    Transplant Proc; 2006 May; 38(4):1014-7. PubMed ID: 16757248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients.
    Nickel P; Presber F; Bold G; Biti D; Schönemann C; Tullius SG; Volk HD; Reinke P
    Transplantation; 2004 Dec; 78(11):1640-6. PubMed ID: 15591953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-reactive cytokine profiles after HLA-identical living-related kidney transplantation.
    Gerrits JH; van de Wetering J; Drabbels JJ; Claas FH; Weimar W; van Besouw NM
    Nephrol Dial Transplant; 2008 Jun; 23(6):2016-23. PubMed ID: 18156655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantation.
    Lúcia M; Luque S; Crespo E; Melilli E; Cruzado JM; Martorell J; Jarque M; Gil-Vernet S; Manonelles A; Grinyó JM; Bestard O
    Kidney Int; 2015 Oct; 88(4):874-87. PubMed ID: 26176829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of influenza immunization on humoral and cellular alloreactivity in humans.
    Danziger-Isakov L; Cherkassky L; Siegel H; McManamon M; Kramer K; Budev M; Sawinski D; Augustine JJ; Hricik DE; Fairchild R; Heeger PS; Poggio ED
    Transplantation; 2010 Apr; 89(7):838-44. PubMed ID: 20179666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor kidney allograft survival associated with positive B cell - Only flow cytometry cross matches: a ten year single center study.
    Norin AJ; Mondragon-Escorpizo MO; Brar A; Hochman D; Sumrani N; Distant DA; Salifu MO
    Hum Immunol; 2013 Oct; 74(10):1304-12. PubMed ID: 23811689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-HLA T-cell reactivity during the first year after HLA-identical living-related kidney transplantation.
    Gerrits JH; van de Wetering J; Drabbels JJ; IJzermans JN; Claas FH; Weimar W; van Besouw NM
    Clin Transplant; 2009; 23(5):740-7. PubMed ID: 19563488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted monitoring of donor-specific HLA antibodies following renal transplantation.
    Almeshari K; Pall A; Chaballout A; Elgamal H; Almana H; Alzayer F; Abaalkhail N; Altalhi M
    Clin Transpl; 2011; ():395-400. PubMed ID: 22755437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-transplant donor-specific Interferon-gamma-producing cells and acute rejection of the kidney allograft.
    Slavcev A; Rybakova K; Svobodova E; Slatinska J; Honsova E; Skibova J; Viklicky O; Striz I
    Transpl Immunol; 2015 Oct; 33(2):63-8. PubMed ID: 26254561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy.
    Martin L; Guignier F; Mousson C; Rageot D; Justrabo E; Rifle G
    Transplantation; 2003 Jul; 76(2):395-400. PubMed ID: 12883199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of anti-HLA antibodies with flow cytometry in needle core biopsies of renal transplants recipients with chronic allograft nephropathy.
    Martin L; Guignier F; Bocrie O; D'Athis P; Rageot D; Rifle G; Justrabo E; Mousson C
    Transplantation; 2005 May; 79(10):1459-61. PubMed ID: 15912120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients.
    Hricik DE; Rodriguez V; Riley J; Bryan K; Tary-Lehmann M; Greenspan N; Dejelo C; Schulak JA; Heeger PS
    Am J Transplant; 2003 Jul; 3(7):878-84. PubMed ID: 12814480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.